focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0192
Bid: 0.0185
Ask: 0.0199
Change: 0.00 (0.00%)
Spread: 0.0014 (7.568%)
Open: 0.0192
High: 0.00
Low: 0.00
Prev. Close: 0.0192
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Loan Facility closes Agreement with Negma

2 Sep 2021 07:00

RNS Number : 5182K
Supply @ME Capital PLC
02 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

02 September 2021

 

Supply@ME Capital plc

(The "Company" or "SYME")

Supply@ME agrees new short-term loan facility to close Agreement with Negma Group

 

Supply@ME Capital plc, the innovative fintech platform which provides an Inventory Monetisation© service to manufacturing and trading companies, is pleased to announce it has signed a term sheet for a short-term loan facility with a family office investor, provided by ARC Group[1] ("ARC").

ARC Group is a global Investment Bank specialising in the middle markets, with representative offices across all continents. The Bank focuses on providing global fundraising solutions to its clients from institutional investors.

Subject to the execution of the definitive agreement, the short-term loan facility will replace the Subscription Agreement previously signed with Negma Group Ltd ("Negma Group"), as per the RNS of 16 June 2021. In relation to the Negma Group facility, the Company has made an application to the London Stock Exchange and the Financial Conduct Authority for admission to trading of 840,000,000 New Ordinary Shares (representing less than 3% of the Company's issued share capital) to be allotted to Negma Group. The remaining outstanding par value of the Convertible Loan Notes not yet converted is £2,106,000 and this residual portion is expected to be repaid in cash, funded by the new short-term loan facility.

Pursuant to the current contract executed with the Company, Negma Group:

- will not undertake any short sales of the Company's Ordinary Shares or any lending of the Company's Ordinary Shares;

- with respect to any disposal of Ordinary Shares on any given day, will not participate in more than twenty five percent (25%) of the daily Value Traded with respect to the Ordinary Shares on such day.

Loan conditions

The new agreement with the family office provided by ARC will help to ensure that the Company continues to be well capitalised and increases its balance sheet flexibility enabling its growth initiatives.

SYME has agreed to the following key terms for the facility:

· Initial tranche of £5 million, with a further £2 million available within 60 days;

· 12-month term, with an interest rate of 10%;

· Warrants will be issued for 20% of the £7 million loan value. The warrants will have a term of 3 years and exercise price of 130% of the lowest closing VWAP over the ten days immediately preceding the issue of the loan.

 

The ARC short-term loan facility will be linked to a Convertible Loan Note facility (CLN), should the Company require cash to facilitate further growth and need to trigger the facility.

 

At the same time SYME will work closely with ARC to further explore a dual listing on NASDAQ. In this regard, SYME will benefit from ARC's expertise in supporting foreign issuers on their journey onto NASDAQ and post-listing.

 

Alessandro Zamboni, CEO, Supply@ME Capital plc, said: "This is a key development for Supply@ME providing us with further flexibility to execute our plans and accelerate our expansion in key markets. ARC was impressed with our recent developments, confirmed by the recent trading update and the related revenue guidance. I am very pleased to strengthen our relationship with ARC at this important stage in our company's growth and I look forward to working with them closely as we further our efforts towards a dual listing. I would like to thank the Negma Group for the support provided which has enabled us to acquire TradeFlow and to support our recent growth initiatives as we move towards securing our first inventory monetisation transactions."

 

Jesús Emilio Hoyos, Managing Partner of ARC Group, said: "As the Financial Advisor to Supply@ME, we are very excited to facilitate this partnership between the Company and this Family Office. We believe that this is the beginning of great journey together and that the funds will help support the future growth of the Company."

 

Notes

The Company enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which is intended to be sold to end-customers or through monetisation of goods and or commodities as part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables creditworthy companies to improve their working capital cycle. The Fund does not target monetisation of inventories owned by companies in financial distress or otherwise seeking to monetise illiquid inventories.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

 

[1] https://www.arccap.us/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGGLKZVGMZG
Date   Source Headline
3rd Oct 202212:22 pmRNSPublication of Prospectus & Total Voting Rights
30th Sep 20224:18 pmRNSTotal Voting Rights
29th Sep 20227:00 amRNS2022 Interim Results
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.